Ignite Creation Date:
2024-05-06 @ 1:37 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04077684
Status:
RECRUITING
Last Update Posted:
2023-10-12
First Post:
2019-09-01
Brief Title:
Efficacy and Safety of Low-dose IL-2 in Patients With SLE a Multicenter Randomised Placebo-controlled Trial
Sponsor:
Peking University Peoples Hospital
Organization:
Peking University Peoples Hospital
Organization Data
Organization:
Peking University Peoples Hospital
Class:
OTHER
Study ID:
2018PHB041-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Peoples Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Zhanguo Li
Responsible Party Title:
Dept Rheumatology and Immunology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Peking University Peoples Hospital
Old Name:
None
Old Organization:
None